MedPath

Nimotuzumab

Generic Name
Nimotuzumab
Drug Type
Biotech
CAS Number
780758-10-3
Unique Ingredient Identifier
6NS400BXKH

Overview

No overview information available.

Indication

Investigated for use/treatment in head and neck cancer, brain cancer, pediatric indications, pancreatic cancer, lung cancer, and colorectal cancer.

Associated Conditions

  • Advanced Head and Neck Cancer
  • Advanced Stage Head and Neck Cancer
  • Glioblastoma Multiforme (GBM)
  • High Grade Glioma (HGG)
  • Advanced Epithelial Tumor of the Head and Neck

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/07/17
Not Applicable
Recruiting
Ming-Yuan Chen
2025/07/08
Not Applicable
Not yet recruiting
2025/05/25
Phase 2
Recruiting
2025/04/22
Phase 2
Not yet recruiting
2025/04/06
Phase 2
Recruiting
Sun Yat-sen University
2025/03/25
Phase 1
Recruiting
2025/03/17
Phase 4
Active, not recruiting
2025/01/17
Phase 3
Completed
2025/01/17
Phase 2
Not yet recruiting
2025/01/13
Phase 2
Active, not recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.